cetrorelix

(redirected from Cetrotide)

cetrorelix

 [set″ro-rel´iks]
a gonadotropin-releasing hormone antagonist, used to inhibit premature luteinizing hormone surges in women undergoing controlled ovarian stimulation during infertility treatment; administered subcutaneously.

cetrorelix

/cet·ro·rel·ix/ (set″ro-rel´iks) a gonadotropin-releasing hormone antagonist, used as the acetate salt to inhibit premature surges of luteinizing hormone in women undergoing controlled ovarian stimulation during infertility treatment.

cetrorelix

[set′rorel′iks]
a gonadotropin-releasing hormone antagonist used to inhibit premature luteinizing hormone surges in women undergoing controlled ovarian stimulation during infertility treatment, administered subcutaneously.
References in periodicals archive ?
M2 EQUITYBITES-April 18, 2013-Aeterna Zentaris Inc to transfer Cetrotide manufacturing rights to Merck KGaA(C)2013 M2 COMMUNICATIONS http://www.
TO) said on Wednesday that it has signed binding agreements with various partners and licensees with respect to the manufacturing rights and obligations for its Cetrotide (cetrorelix acetate for injection), which is used to regulate hormone responses in women undergoing infertility treatment.
M2 PHARMA-April 18, 2013-Aeterna Zentaris Inc to transfer Cetrotide manufacturing rights to Merck KGaA(C)2013 M2 COMMUNICATIONS
today announced the release of Cetrotide (generic name: Cetrorelix acetate), indicated for the prevention of premature ovulation.
The lead LHRH antagonist compound, cetrorelix, is currently marketed for in vitro fertilization under the brand name Cetrotide.
The slow market growth is attributed to the patent expiry of the branded products such as Cetrotide and Ovidrel in 2015.
5m for the same quarter in 2011 due to lower deliveries of Cetrotide to certain customers and to the relative weakening of the euro against the US dollar.
Tokyo, Japan, Sept 21, 2006 - (JCN) - Shionogi and Nippon Kayaku announced on September 21 the launch in Japan of Cetrotide - cetrorelix acetate, for prevention of premature ovulation during
Some key branded products such as Cetrotide, GONAL-f, Crinone, Ovidrel, Luveris, Pergoveris and Puregon are going to face severe threats from generics as they approach patent expiry between 2010 and 2015.
This improvement was said to be due to a reduction in net R&D costs, lower SG&A expenses and lower depreciation and amortisation charges, as well as higher net foreign exchange gains, offset by the significant reduction in licence fee revenues and a lower margin on sales of Cetrotide.
Tokyo, Japan, Apr 21, 2006 - (JCN) - Shionogi and Nippon Kayaku jointly announced on April 20 that they have received approval for Cetrotide, an agent for preventing premature ovulation, from the Ministry of Health, Labor and Welfare.